Alfresa Corporation (Head office: Chiyoda-ku, Tokyo; Representative Director & President: Yusuke Fukujin) subscribed to a part of new shares which Gene Therapy Research Institution Co., Ltd. offered to raise capital in a third-party allotment.

・Press Release